SEC Form 4 · accession 0001104659-16-124834
Axsome Therapeutics, Inc. · AXSM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark E Saad
Director
Period of report
May 27, 2016
Accepted (ET)
Jun 1, 2016 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001579428
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $8.02 | May 27, 2016 | A | 6,231 | A | — | May 26, 2026 | Common Stock | 6,231 | 6,231 | D |
Explanation of responses
- F1The option vested in full on the date of grant. The grant represents options elected to be received in lieu of cash compensation earned in 2015.